Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

Takashi Kasai, Takahiko Tokuda, Ryotaro Ishii, Noriko Ishigami, Yoshio Tsuboi, Masanori Nakagawa, Toshiki Mizuno, Omar Ali El-Agnaf

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Recent studies have shown that cerebrospinal fluid (CSF) levels of α-synuclein (α-syn) are highly elevated in patients with Creutzfeldt-Jakob disease (CJD) compared to controls. However, the diagnostic value of CSF α-syn in CJD has not been established. To confirm whether CSF α-syn is increased in CJD and is a useful marker for this disease, two independent enzyme-linked immunoabsorbent assays (ELISAs) specific for α-syn were used: ELISA 211-FL140, which is specific for full-length α-syn, and ELISA N19-FL140, which is specific for the full-length and associated C-terminal truncated forms of α-syn. CSF samples from 24 patients with CJD and 24 controls were assessed in this study. We found that samples from the CJD patients showed significantly higher levels of CSF α-syn compared to controls in both ELISA (211-FL140 or N19-FL140) tests (P = 0.0467 and P = 0.0010, respectively). However, there was a considerable overlap in the concentration ranges of the two groups of subjects. We also measured the levels of total tau (t-tau) protein in these samples and found that CSF t-tau levels were 5-10-times higher in the CJD group (P < 0.0001) compared with the controls. When the CSF t-tau and α-syn levels were combined, the area under the ROC curve (AUC) was slightly increased in clinically diagnosed CJD cases (AUC of 0.964) relative to an AUC of 0.943 for increased CSF t-tau alone. The combined use of CSF α-syn and t-tau levels may be a useful biomarker for the diagnosis of CJD.

Original languageEnglish
Pages (from-to)1203-1209
Number of pages7
JournalJournal of Neurology
Volume261
Issue number6
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Synucleins
Creutzfeldt-Jakob Syndrome
Cerebrospinal Fluid
ROC Curve
Area Under Curve
Enzymes
tau Proteins
Biomarkers

Keywords

  • Biomarker
  • Cerebrospinal fluid
  • Creutzfeldt-Jakob disease
  • ELISA
  • Tau
  • α-Synuclein

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. / Kasai, Takashi; Tokuda, Takahiko; Ishii, Ryotaro; Ishigami, Noriko; Tsuboi, Yoshio; Nakagawa, Masanori; Mizuno, Toshiki; Ali El-Agnaf, Omar.

In: Journal of Neurology, Vol. 261, No. 6, 2014, p. 1203-1209.

Research output: Contribution to journalArticle

Kasai, T, Tokuda, T, Ishii, R, Ishigami, N, Tsuboi, Y, Nakagawa, M, Mizuno, T & Ali El-Agnaf, O 2014, 'Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease', Journal of Neurology, vol. 261, no. 6, pp. 1203-1209. https://doi.org/10.1007/s00415-014-7334-7
Kasai, Takashi ; Tokuda, Takahiko ; Ishii, Ryotaro ; Ishigami, Noriko ; Tsuboi, Yoshio ; Nakagawa, Masanori ; Mizuno, Toshiki ; Ali El-Agnaf, Omar. / Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. In: Journal of Neurology. 2014 ; Vol. 261, No. 6. pp. 1203-1209.
@article{4eff07abb19c471c81a5c26f7c274a6d,
title = "Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease",
abstract = "Recent studies have shown that cerebrospinal fluid (CSF) levels of α-synuclein (α-syn) are highly elevated in patients with Creutzfeldt-Jakob disease (CJD) compared to controls. However, the diagnostic value of CSF α-syn in CJD has not been established. To confirm whether CSF α-syn is increased in CJD and is a useful marker for this disease, two independent enzyme-linked immunoabsorbent assays (ELISAs) specific for α-syn were used: ELISA 211-FL140, which is specific for full-length α-syn, and ELISA N19-FL140, which is specific for the full-length and associated C-terminal truncated forms of α-syn. CSF samples from 24 patients with CJD and 24 controls were assessed in this study. We found that samples from the CJD patients showed significantly higher levels of CSF α-syn compared to controls in both ELISA (211-FL140 or N19-FL140) tests (P = 0.0467 and P = 0.0010, respectively). However, there was a considerable overlap in the concentration ranges of the two groups of subjects. We also measured the levels of total tau (t-tau) protein in these samples and found that CSF t-tau levels were 5-10-times higher in the CJD group (P < 0.0001) compared with the controls. When the CSF t-tau and α-syn levels were combined, the area under the ROC curve (AUC) was slightly increased in clinically diagnosed CJD cases (AUC of 0.964) relative to an AUC of 0.943 for increased CSF t-tau alone. The combined use of CSF α-syn and t-tau levels may be a useful biomarker for the diagnosis of CJD.",
keywords = "Biomarker, Cerebrospinal fluid, Creutzfeldt-Jakob disease, ELISA, Tau, α-Synuclein",
author = "Takashi Kasai and Takahiko Tokuda and Ryotaro Ishii and Noriko Ishigami and Yoshio Tsuboi and Masanori Nakagawa and Toshiki Mizuno and {Ali El-Agnaf}, Omar",
year = "2014",
doi = "10.1007/s00415-014-7334-7",
language = "English",
volume = "261",
pages = "1203--1209",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "D. Steinkopff-Verlag",
number = "6",

}

TY - JOUR

T1 - Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

AU - Kasai, Takashi

AU - Tokuda, Takahiko

AU - Ishii, Ryotaro

AU - Ishigami, Noriko

AU - Tsuboi, Yoshio

AU - Nakagawa, Masanori

AU - Mizuno, Toshiki

AU - Ali El-Agnaf, Omar

PY - 2014

Y1 - 2014

N2 - Recent studies have shown that cerebrospinal fluid (CSF) levels of α-synuclein (α-syn) are highly elevated in patients with Creutzfeldt-Jakob disease (CJD) compared to controls. However, the diagnostic value of CSF α-syn in CJD has not been established. To confirm whether CSF α-syn is increased in CJD and is a useful marker for this disease, two independent enzyme-linked immunoabsorbent assays (ELISAs) specific for α-syn were used: ELISA 211-FL140, which is specific for full-length α-syn, and ELISA N19-FL140, which is specific for the full-length and associated C-terminal truncated forms of α-syn. CSF samples from 24 patients with CJD and 24 controls were assessed in this study. We found that samples from the CJD patients showed significantly higher levels of CSF α-syn compared to controls in both ELISA (211-FL140 or N19-FL140) tests (P = 0.0467 and P = 0.0010, respectively). However, there was a considerable overlap in the concentration ranges of the two groups of subjects. We also measured the levels of total tau (t-tau) protein in these samples and found that CSF t-tau levels were 5-10-times higher in the CJD group (P < 0.0001) compared with the controls. When the CSF t-tau and α-syn levels were combined, the area under the ROC curve (AUC) was slightly increased in clinically diagnosed CJD cases (AUC of 0.964) relative to an AUC of 0.943 for increased CSF t-tau alone. The combined use of CSF α-syn and t-tau levels may be a useful biomarker for the diagnosis of CJD.

AB - Recent studies have shown that cerebrospinal fluid (CSF) levels of α-synuclein (α-syn) are highly elevated in patients with Creutzfeldt-Jakob disease (CJD) compared to controls. However, the diagnostic value of CSF α-syn in CJD has not been established. To confirm whether CSF α-syn is increased in CJD and is a useful marker for this disease, two independent enzyme-linked immunoabsorbent assays (ELISAs) specific for α-syn were used: ELISA 211-FL140, which is specific for full-length α-syn, and ELISA N19-FL140, which is specific for the full-length and associated C-terminal truncated forms of α-syn. CSF samples from 24 patients with CJD and 24 controls were assessed in this study. We found that samples from the CJD patients showed significantly higher levels of CSF α-syn compared to controls in both ELISA (211-FL140 or N19-FL140) tests (P = 0.0467 and P = 0.0010, respectively). However, there was a considerable overlap in the concentration ranges of the two groups of subjects. We also measured the levels of total tau (t-tau) protein in these samples and found that CSF t-tau levels were 5-10-times higher in the CJD group (P < 0.0001) compared with the controls. When the CSF t-tau and α-syn levels were combined, the area under the ROC curve (AUC) was slightly increased in clinically diagnosed CJD cases (AUC of 0.964) relative to an AUC of 0.943 for increased CSF t-tau alone. The combined use of CSF α-syn and t-tau levels may be a useful biomarker for the diagnosis of CJD.

KW - Biomarker

KW - Cerebrospinal fluid

KW - Creutzfeldt-Jakob disease

KW - ELISA

KW - Tau

KW - α-Synuclein

UR - http://www.scopus.com/inward/record.url?scp=84903638867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903638867&partnerID=8YFLogxK

U2 - 10.1007/s00415-014-7334-7

DO - 10.1007/s00415-014-7334-7

M3 - Article

C2 - 24737170

AN - SCOPUS:84903638867

VL - 261

SP - 1203

EP - 1209

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 6

ER -